ST
MDGL icon

Spot Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Spot Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-286
Closed -$4K – 3754
2015
Q4 		$4K Hold
286
– – ﹤0.01% 3434
2015
Q3 		$17K Hold
286
– – ﹤0.01% 3539
2015
Q2 		$22K Buy
+286
New +$24K ﹤0.01% 3450

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Spot Trading's MDGL Position: Q1 2016 in Review

Spot Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2016, closing a stake of 14 shares.

Spot Trading first reported a position in MDGL in Q1 2014 and held it in 4 quarters. The position peaked at $69K in Q1 2014. 68 funds tracked by Wall St. Rank hold MDGL as of Q1 2016.

  • Spot Trading reported no remaining Madrigal Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 14 Madrigal Pharmaceuticals shares in Q1 2016.
  • Spot Trading first reported a position in Madrigal Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Spot Trading's Madrigal Pharmaceuticals position peaked at $69K in Q1 2014.
  • 68 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.